巨子 ICON - 財經股票資訊及專家分析
搜尋 股票

Cellectar Biosciences

CLRB
最少15分鐘延遲,股票資訊由第三方資訊供應商提供
・Cellectar Biosciences - 延遲價格・最後更新於 14/01 12:14
最高位
0.699
最低位
0.680
開市價
--
前收市價
0.700
成交量(千)
2.10
成交額(百萬)
0.00
買入
--
賣出
--
每手股數
--
市值(百萬)
42.70
市盈率
--
息率
--
差價
--
52週高低
2.980 - 0.582
所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

企業資料

公司名稱
Cellectar Biosciences
證券代碼
CLRB.US
所屬板塊
Biotechnology
公司業務
Cellectar Biosciences Inc is a clinical stage biopharmaceutical company. It focusses on development of targeted phospholipid drug conjugates for the treatment and imaging of cancer. The company's pipeline consists of pre-clinical and clinical product candidates including radiotherapeutic and chemotherapeutic phospholipid drug conjugates. Its portfolio of products in development includes CLR 131, CTX Product Portfolio consisting of CTX CLR 1800-P, CTX CLR 1602-PTX and CTX CLR 1700, CLR 125, CLR 124, and CLR 1502.
發行量
50504064
公司總部
100 Campus Drive
公司網址
http://www.cellectar.com
公司電郵
epiros@rodmanandrenshaw.com
公司電話
+1 608 441-8120
暫無內容

關於

Cellectar Biosciences(CLRB.US)所屬的行業板塊為Biotechnology。
Cellectar Biosciences Inc is a clinical stage biopharmaceutical company. It focusses on development of targeted phospholipid drug conjugates for the treatment and imaging of cancer. The company's pipeline consists of pre-clinical and clinical product candidates including radiotherapeutic and chemotherapeutic phospholipid drug conjugates. Its portfolio of products in development includes CLR 131, CTX Product Portfolio consisting of CTX CLR 1800-P, CTX CLR 1602-PTX and CTX CLR 1700, CLR 125, CLR 124, and CLR 1502.
詳細公司背景可參考: http://www.cellectar.com